Published in Am J Med on January 01, 1983
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49
Temporal dynamics of the human vaginal microbiota. Sci Transl Med (2012) 4.58
Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol (1983) 4.42
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (2008) 4.21
Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol (1989) 4.03
Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol (2007) 3.10
Comparison of methods for diagnosing bacterial vaginosis among pregnant women. J Clin Microbiol (1989) 3.06
Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One (2012) 2.79
Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol (2008) 2.73
Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol (2002) 2.67
Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One (2010) 2.62
Deep sequencing of the vaginal microbiota of women with HIV. PLoS One (2010) 2.59
The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis (2009) 2.56
Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect (2005) 2.55
From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev (2010) 2.42
The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG (2011) 2.41
Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol (2009) 2.29
Bacterial vaginosis. Clin Microbiol Rev (1991) 2.27
Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect (2002) 2.25
Reproducibility of interpretation of Gram-stained vaginal smears for the diagnosis of bacterial vaginosis. J Clin Microbiol (1990) 2.22
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis (2008) 2.21
Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect (2005) 2.20
The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Sex Transm Infect (2011) 2.19
Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health (1992) 2.16
Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis (2009) 2.16
Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med (2012) 2.06
Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol (2007) 2.06
Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics (2010) 2.04
Use of a sodium polyanetholesulfonate disk for the identification of Gardnerella vaginalis. J Clin Microbiol (1985) 1.97
Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol (2012) 1.94
A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol (2007) 1.93
Evaluation of affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis. J Clin Microbiol (1994) 1.89
Factors that influence the rate of epithelial maturation in the cervix in healthy young women. J Adolesc Health (2009) 1.89
Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med (2011) 1.89
Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol (2010) 1.89
Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria. Sex Transm Infect (2008) 1.83
Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect (2010) 1.80
Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis. J Clin Microbiol (1997) 1.77
Clinical algorithms for the screening of Chlamydia trachomatis in Turkish women. Genitourin Med (1996) 1.76
Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol (2000) 1.74
Vaginal douching: evidence for risks or benefits to women's health. Epidemiol Rev (2002) 1.71
Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol (2010) 1.69
Severity of bacterial vaginosis and the risk of sexually transmitted infection. Am J Obstet Gynecol (2011) 1.69
Gardnerella vaginalis: characteristics, clinical considerations, and controversies. Clin Microbiol Rev (1992) 1.67
Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev (2007) 1.65
A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis. Am J Epidemiol (2008) 1.63
Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol (2005) 1.60
Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis (2010) 1.59
Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women. Ann Intern Med (2008) 1.59
Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women. J Clin Microbiol (2002) 1.59
The role of bacterial vaginosis as a cause of amniotic fluid infection, chorioamnionitis and prematurity--a review. Arch Gynecol Obstet (1990) 1.54
Interpreting the epidemiology and natural history of bacterial vaginosis: are we still confused? Anaerobe (2011) 1.50
Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women. Menopause (2015) 1.49
Urogenital schistosomiasis in women of reproductive age in Tanzania's Lake Victoria region. Am J Trop Med Hyg (2011) 1.49
Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis. PLoS One (2010) 1.47
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Invest (2011) 1.44
Recent advances in understanding the microbiology of the female reproductive tract and the causes of premature birth. Infect Dis Obstet Gynecol (2010) 1.43
The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One (2014) 1.43
Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol (2007) 1.41
Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun (2006) 1.40
Treating asymptomatic bacterial vaginosis in pregnancy. Can Fam Physician (2002) 1.39
Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus La-14 Attenuate Gardnerella vaginalis-Infected Bacterial Vaginosis in Mice. Nutrients (2017) 1.39
Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol (1992) 1.38
HIV among pregnant women in Moshi Tanzania: the role of sexual behavior, male partner characteristics and sexually transmitted infections. AIDS Res Ther (2006) 1.37
Is bacterial vaginosis a sexually transmitted infection? Sex Transm Infect (2001) 1.36
Validation data-based adjustments for outcome misclassification in logistic regression: an illustration. Epidemiology (2011) 1.35
Bacterial vaginosis in women attending STD clinic: diagnostic criteria and prevalence of Mobiluncus spp. Genitourin Med (1987) 1.32
Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis. J Clin Microbiol (1999) 1.30
Testing for sexually transmitted infections: a brave new world? Sex Transm Infect (2006) 1.30
Effect of concurrent lower genital tract infections on cervical cancer screening. Genitourin Med (1997) 1.30
Prevalence and abundance of uncultivated Megasphaera-like bacteria in the human vaginal environment. Appl Environ Microbiol (2008) 1.29
Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health (2008) 1.28
Comparative study of vaginal Lactobacillus phages isolated from women in the United States and Turkey: prevalence, morphology, host range, and DNA homology. Clin Diagn Lab Immunol (2001) 1.28
Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome (2013) 1.28
Genital tract leukocytes and shedding of genital HIV type 1 RNA. Clin Infect Dis (2008) 1.25
Prevalence of sexually transmitted infections among pregnant women with known HIV status in northern Tanzania. Reprod Health (2009) 1.25
Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West Africa. BMC Infect Dis (2005) 1.24
Association of Schistosomiasis and HIV infection in Tanzania. Am J Trop Med Hyg (2012) 1.23
The aetiology of bacterial vaginosis. J Appl Microbiol (2011) 1.22
Composition of the vaginal microbiota in women of reproductive age--sensitive and specific molecular diagnosis of bacterial vaginosis is possible? PLoS One (2013) 1.21
Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology (2014) 1.20
Understanding vaginal microbiome complexity from an ecological perspective. Transl Res (2012) 1.19
Metabolic signatures of bacterial vaginosis. MBio (2015) 1.18
Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol (2007) 1.17
A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infect Dis Obstet Gynecol (2001) 1.17
Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians. Sex Transm Infect (2010) 1.16
Preterm birth due to maternal infection: Causative pathogens and modes of prevention. Eur J Clin Microbiol Infect Dis (2006) 1.16
Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis. J Clin Microbiol (2005) 1.16
Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis (2009) 1.15
Bacterial vaginosis is not associated with circumcision status of the current male partner. Sex Transm Infect (1999) 1.15
Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. ISME J (2014) 1.14
Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding. Sex Transm Infect (2004) 1.13
Molecular definition of vaginal microbiota in East African commercial sex workers. Appl Environ Microbiol (2011) 1.13
Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J Bacteriol (2012) 1.13
Analysis of vaginal lactobacilli from healthy and infected Brazilian women. Appl Environ Microbiol (2008) 1.12
The microbiota of the vagina and its influence on women's health and disease. Am J Med Sci (2012) 1.11
Non-volatile fatty acids in the diagnosis of non-specific vaginitis. J Clin Pathol (1983) 1.11
Antibody-based detection and inhibition of vaginolysin, the Gardnerella vaginalis cytolysin. PLoS One (2009) 1.10
Quantitative microbiologic models for preterm delivery. J Clin Microbiol (2003) 1.10
Glycerol monolaurate inhibits Candida and Gardnerella vaginalis in vitro and in vivo but not Lactobacillus. Antimicrob Agents Chemother (2009) 1.09
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med (1996) 11.91
Etiology of nongonococcal urethritis. N Engl J Med (1975) 9.61
Diagnosis of coliform infection in acutely dysuric women. N Engl J Med (1982) 8.75
Characterization of plasmid deoxyribonucleic acid from Neisseria gonorrhoeae. Infect Immun (1974) 8.30
Disseminated gonococcal infections caused by Neisseria gonorrhoeae with unique nutritional requirements. J Infect Dis (1975) 7.92
Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med (1983) 7.89
The serological classification of Neisseria gonorrhoeae. I. Isolation of the outer membrane complex responsible for serotypic specificity. J Exp Med (1976) 7.85
Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med (1978) 7.07
Causes of the acute urethral syndrome in women. N Engl J Med (1980) 6.91
Anaerobic bacteria in nonspecific vaginitis. N Engl J Med (1980) 6.74
Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J Infect Dis (1985) 6.32
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96
Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance. N Engl J Med (1974) 5.68
Disseminated gonococcal infection. Ann Intern Med (1971) 5.66
Serological classification of Neisseria gonorrhoeae with monoclonal antibodies. Infect Immun (1982) 5.54
Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera. J Clin Invest (1976) 5.54
Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis (1984) 5.40
Clinical spectrum of pharyngeal gonococcal infection. N Engl J Med (1973) 5.34
A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med (1988) 5.32
Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med (1975) 4.99
Neisseria pili proteins: amino-terminal amino acid sequences and identification of an unusual amino acid. Biochemistry (1978) 4.95
Quantitative determination of antibody to gonococcal pili. Changes in antibody levels with gonococcal infection. J Clin Invest (1973) 4.90
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74
AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med (1986) 4.68
Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA (1986) 4.62
Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol (1983) 4.42
Selective differential human blood bilayer media for isolation of Gardnerella (Haemophilus) vaginalis. J Clin Microbiol (1982) 4.28
Characterization of Campylobacter-like organisms isolated from homosexual men. J Infect Dis (1984) 4.23
Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23
Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol (1989) 4.03
Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol (1986) 3.67
A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med (1982) 3.66
Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother (1985) 3.66
Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol (1988) 3.66
Isolation of viruses, bacteria and other organisms from venereal disease clinic patients: methodology and problems associated with multiple isolations. Health Lab Sci (1973) 3.62
Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med (1992) 3.56
Low antibiotic resistance of gonococci causing disseminated infection. N Engl J Med (1973) 3.48
An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol (1970) 3.46
Evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother (1973) 3.44
Studies of venereal disease. 3. Double-blind comparison of tetracycline hydrochloride and placebo in treatment of nongonococcal urethritis. JAMA (1967) 3.40
The Chlamydia epidemic. JAMA (1981) 3.35
Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N Engl J Med (1980) 3.33
Epidemiology of genital human papillomavirus infection. Epidemiol Rev (1988) 3.32
Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med (1981) 3.32
National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA (1990) 3.25
Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis (1996) 3.23
Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun (1983) 3.22
Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum. J Clin Invest (1977) 3.18
Chlamydia trachomatis as a cause of acute "idiopathic" epididymitis. N Engl J Med (1978) 3.16
Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect (2006) 3.16
The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12
DNA hybridization technique for the detection of Neisseria gonorrhoeae in men with urethritis. J Infect Dis (1983) 3.11
Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody. J Clin Microbiol (1975) 3.03
Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02
Clinical manifestations of vaginal trichomoniasis. JAMA (1989) 2.97
Identification of Gardnerella (Haemophilus) vaginalis. J Clin Microbiol (1982) 2.96
Characterization of Neisseria cinerea, a nonpathogenic species isolated on Martin-Lewis medium selective for pathogenic Neisseria spp. J Clin Microbiol (1984) 2.92
Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med (1984) 2.89
Studies of venereal disease. II. Observations on the incidence, etiology, and treatment of the postgonococcal urethritis syndrome. JAMA (1967) 2.84
Problems, solutions, and challenges in syndromic management of sexually transmitted diseases. Sex Transm Infect (1998) 2.83
Sexual mixing patterns of patients attending sexually transmitted diseases clinics. Sex Transm Dis (1996) 2.76
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
Sexually transmitted diseases in victims of rape. N Engl J Med (1990) 2.74
Complete nucleotide sequence and genome organization of bovine parvovirus. J Virol (1986) 2.69
Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob Agents Chemother (1991) 2.68
Sexual bridging by Cambodian men: potential importance for general population spread of STD and HIV epidemics. Sex Transm Dis (2000) 2.66
Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65
Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis (1985) 2.64
Single oral dose ampicillin-probenecid treatment of gnorrhea in the male. JAMA (1971) 2.56
Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA (1982) 2.55
Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules. Infect Immun (1982) 2.55
Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health (1999) 2.54
Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations. Ann Intern Med (1984) 2.44
Spectinomycin versus tetracycline for the treatment of gonorrhea. N Engl J Med (1977) 2.44
Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis (1989) 2.41
Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA (1993) 2.41
Asymptomatic gonorrhea in men: caused by gonococci with unique nutritional requirements. Science (1977) 2.37
Epidemiology of penicillinase-producing Neisseria gonorrhoeae infections: analysis by auxotyping and serogrouping. N Engl J Med (1982) 2.36
Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention. Ann Intern Med (1983) 2.33
Prevalence and characterization of hippurate-negative Campylobacter jejuni in King County, Washington. J Clin Microbiol (1987) 2.33
Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol (1977) 2.31
Spectinomycin and penicillin G in the treatment of gonorrhea. A comparative evaluation. JAMA (1972) 2.30
Epidemiology of gonorrhea: distribution and temporal changes in auxotype/serovar classes of Neisseria gonorrhoeae. Sex Transm Dis (1987) 2.27
Circumcision and sexually transmitted diseases. Am J Public Health (1994) 2.27
Amine content of vaginal fluid from untreated and treated patients with nonspecific vaginitis. J Clin Invest (1979) 2.25